B

Biocytogen Pharmaceuticals Beijing Co Ltd
HKEX:2315

Watchlist Manager
Biocytogen Pharmaceuticals Beijing Co Ltd
HKEX:2315
Watchlist
Price: 5.6 HKD -2.78% Market Closed
Market Cap: 2.2B HKD
Have any thoughts about
Biocytogen Pharmaceuticals Beijing Co Ltd?
Write Note

Operating Margin
Biocytogen Pharmaceuticals Beijing Co Ltd

-17.5%
Current
-45%
Average
-7.9%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-17.5%
=
Operating Profit
-139.8m
/
Revenue
800.6m

Operating Margin Across Competitors

Country CN
Market Cap 2.2B HKD
Operating Margin
-17%
Country FR
Market Cap 6T USD
Operating Margin
-17 527%
Country US
Market Cap 300.2B USD
Operating Margin
28%
Country US
Market Cap 158.7B USD
Operating Margin
19%
Country US
Market Cap 126.8B USD
Operating Margin
40%
Country US
Market Cap 115B USD
Operating Margin
38%
Country US
Market Cap 94.1B EUR
Operating Margin
-370%
Country AU
Market Cap 137.3B AUD
Operating Margin
26%
Country US
Market Cap 88.3B USD
Operating Margin
30%
Country US
Market Cap 39.3B EUR
Operating Margin
-33%
Country NL
Market Cap 34.1B EUR
Operating Margin
-22%

Profitability Report

View the profitability report to see the full profitability analysis for Biocytogen Pharmaceuticals Beijing Co Ltd.

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-17.5%
=
Operating Profit
-139.8m
/
Revenue
800.6m
What is the Operating Margin of Biocytogen Pharmaceuticals Beijing Co Ltd?

Based on Biocytogen Pharmaceuticals Beijing Co Ltd's most recent financial statements, the company has Operating Margin of -17.5%.